Gene · 10498
Papers2,160
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,160
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting CARM1 impairs DNA damage repair and attenuates B-cell acute lymphoblastic leukemia progression. | Biochim Biophys Acta Mol Basis Dis | 2027 | 42669369 | PubTator, text mining | PubMed |
| CARM1 as a therapeutic target: The future of disease-modifying therapies for epilepsy. | Mol Cell Neurosci | 2026 | 42716264 | PubTator, text mining | PubMed |
| CARM1 in human cancer: a multifunctional epigenetic node driving tumor plasticity and therapeutic vulnerability. | Biochim Biophys Acta Rev Cancer | 2026 | 42679970 | PubTator, text mining | PubMed |
| CARM1: an epigenetic brake on cDC1-mediated antitumor immunity. | Trends Immunol | 2026 | 42618461 | PubTator, text mining | PubMed |
| A bibliometric and visual analysis of PRMTs research publications for cancer (2006-2024). | Medicine (Baltimore) | 2026 | 42601760 | PubTator, text mining | PubMed |
| Decoding the Complexity of Hepatocellular Carcinoma: Clinical Challenges and Targeting HuR as a Novel Therapeutic Strategy. | Livers | 2026 | 42583674 | PubTator, text mining | PubMed |
| Depletion of CARM1 slows in vivo tumorigenicity and rewires developmental programming in glioma stem-like cells. | Cell Rep | 2026 | 42570242 | PubTator, text mining | PubMed |
| Targeting PRMTs with small-molecule inhibitors: a comprehensive review. | RSC Med Chem | 2026 | 42549137 | PubTator, text mining | PubMed |
| Protein arginine methyltransferases as regulators of phase separation: implications in cancer and neurodegenerative diseases. | Eur Biophys J | 2026 | 42484672 | PubTator, text mining | PubMed |
| A novel combination approach targeting P300 and DNA-PK exploits epigenetic dependencies in acute myeloid leukemia. | Mol Ther Oncol | 2026 | 42440809 | PubTator, text mining | PubMed |
| The CARM1 epigenetic enzyme inhibits cross-presenting dendritic cell function in cancer immunity. | Science | 2026 | 42424445 | PubTator, text mining | PubMed |
| Beyond KEAP1: The Context-Specific NRF2 Partner Code in Disease and Therapy. | Antioxidants (Basel) | 2026 | 42352065 | PubTator, text mining | PubMed |
| oHSV-1-modulated m6A methylation reprogramming through ALKBH5-mediated suppression of CARM1 induced apoptosis in glioblastoma. | Virol J | 2026 | 42343346 | PubTator, text mining | PubMed |
| NRF2-Driven CARM1 Promotes Malignant Progression and Ferroptosis Resistance in Breast Cancer. | Curr Cancer Drug Targets | 2026 | 42304927 | PubTator, text mining | PubMed |
| CircRNAs derived from the tyrosine phosphatase PTPN22 impact chemosensitivity in ALK-positive T-cell lymphomas. | Sci Rep | 2026 | 42243281 | PubTator, text mining | PubMed |
| Arginine methylation of BAF155 regulates interactions with RNA processing machinery. | bioRxiv | 2026 | 42239058 | PubTator, text mining | PubMed |
| Hypoxia-Associated Alternative Polyadenylation of CARM1 and Tumor Microenvironment Alterations in Non-Small Cell Lung Cancer. | Genes (Basel) | 2026 | 42194962 | PubTator, text mining | PubMed |
| From scaffold to selectivity-medicinal insights of PRMT1 and PRMT4 inhibitors for epigenetic cancer therapy. | RSC Med Chem | 2026 | 42158338 | PubTator, text mining | PubMed |
| Targeting RANKL-independent osteoclastogenesis overcomes denosumab resistance in models of ER+ breast cancer bone metastasis. | J Clin Invest | 2026 | 42138086 | PubTator, text mining | PubMed |
| Correction to "Inhibition of CARM1-Mediated Methylation of ACSL4 Promotes Ferroptosis in Colorectal Cancer". | Adv Sci (Weinh) | 2026 | 42126526 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10498/papers